Skip to main content
. 2022 Oct 19;21:217. doi: 10.1186/s12933-022-01645-y

Table 1.

Patient baseline characteristics according to tertiles of stress hyperglycemia ratio

Total (n = 8196) T1 (n = 2732) T2 (n = 2730) T3 (n = 2734) P-value
Age (years) 68 ± 11 69 ± 10 68 ± 11 67 ± 11 <0.001*
Male (n, %) 5266 (64.25%) 1659 (60.72%) 1726 (63.22%) 1881 (68.80%) <0.001*
BMI (Kg/m2) 25.57 ± 3.41 25.39 ± 3.42 25.57 ± 3.34 25.72 ± 3.45 <0.001*
HR (beats/min) 78 ± 13 77 ± 13 77 ± 13 79 ± 14 <0.001*
SBP (mmHg) 136 ± 19 136 ± 19 136 ± 18 137 ± 20 0.138
DBP (mmHg) 77 ± 12 76 ± 13 77 ± 12 77 ± 12 <0.001*
Smoking (n, %) 3524 (43.00%) 1113 (40.74%) 1163 (42.60%) 1248 (45.65%) 0.001*
Drinking (n, %) 4672 (57.00%) 1466 (53.66%) 1565 (57.33%) 1641 (60.02%) <0.001*
Hypertension (n, %) 5894 (71.91%) 1992 (72.91%) 1909 (69.93%) 1993 (72.90%) 0.018*
NGR (n, %) 1395 (17.02%) 149 (5.45%) 567 (20.77%) 679 (24.84%) <0.001*
Pre-DM (n, %) 2389 (29.15%) 842 (30.82%) 1016 (37.22%) 531 (19.42%) <0.001*
DM (n, %) 4412 (53.83%) 1741 (63.73%) 1147 (42.01%) 1524 (55.74%) <0.001*
ACS (n, %) 3001 (36.62%) 906 (33.16%) 1004 (36.78%) 1091 (39.90%) <0.001*
Glucose (mmol/l) 6.55 ± 2.39 5.52 ± 1.30 5.96 ± 1.32 8.17 ± 3.12 <0.001*
HbA1c (%) 6.80 ± 1.38 7.22 ± 1.53 6.46 ± 1.06 6.71 ± 1.40 <0.001*
HDL-C (mg/dL) 1.06 ± 0.27 1.08 ± 0.28 1.07 ± 0.26 1.03 ± 0.27 <0.001*
LDL-C (mg/dL) 2.17 ± 0.83 2.10 ± 0.80 2.21 ± 0.85 2.21 ± 0.83 <0.001*
TC (mg/dL) 3.81 ± 0.98 3.72 ± 0.95 3.85 ± 0.99 3.87 ± 0.99 <0.001*
TG (mg/dL) 1.43 ± 0.94 1.31 ± 0.82 1.44 ± 0.89 1.57 ± 1.07 <0.001*
eGFR (ml/min) 84.68 ± 17.49 82.98 ± 17.88 86.22 ± 16.04 84.84 ± 18.32 <0.001*
Medications
Antiplatelets (n, %) 6844 (83.60%) 2284 (83.60%) 2318 (84.91%) 2242 (82.00%) 0.015*
Antihypertensive drugs (n, %) 6200 (76.65%) 2086 (76.35%) 2071 (75.86%) 2043 (74.73%) 0.355
Antilipidemic drugs (n, %) 6901 (84.20%) 2306 (84.41%) 2362 (86.52%) 2233 (81.68%) <0.001*

* Statistically significant P values